ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1364	National Cancer Institute	Html	en	Sleep Disorders (PDQ®)–Health Professional Version	Expert-reviewed information summary about causes and management of sleep disorders in people with cancer.	slow wave sleep 0.645037 sleep difficulty 0.586858 circadian sleep disorder 0.585999 sleep disturbance 0.734742 general sleep 0.627531 self-reported sleep 0.586211 sleep disturbances 0.78937 sleep environment 0.599417 general sleep hygiene 0.610843 sleep history 0.590036 poor sleep hygiene 0.618457 sleep patterns 0.707388 individual sleep patterns 0.650508 sleep cycle. 0.613137 sleep diary 0.632064 subjective sleep quality 0.612249 sleep disruption 0.616368 severe sleep 0.619271 sleep medicine report 0.579291 Pittsburgh Sleep Quality 0.612644 8-hour sleep period. 0.649042 General Sleep Disturbance 0.626985 different sleep trajectories 0.61732 secondary sleep disorders 0.654958	behavioral therapy 0.643973 cancer experience sleep 0.697426 numerous sleep parameters 0.602184 sleep education 0.598942 REM sleep 0.663854 sleep 0.906331 diary-measured sleep variables 0.59623 sleep cycle 0.621195 sleep outcomes 0.569139 sleep medicine 0.672639 common sleep disturbance 0.63638 total sleep time 0.611253 sleep quality 0.73817 sleep disorders 0.662401 progressively deepening sleep 0.64769 Adequate sleep 0.615183 sleep restriction 0.71475 severe sleep disturbances 0.604554 breast cancer 0.670406 insomnia 0.65868 randomized controlled trial 0.60112 severe sleep disorder 0.613455 sleep hygiene 0.685071 NREM sleep 0.616861	CLICK HERE
1466	National Cancer Institute	Html	en	Penile Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of penile cancer.	penile shaft 0.625965 lower prevalence 0.447004 disease stage 0.456978 odds ratio 0.446539 infected primary lesion 0.547017 PDQ cancer information 0.772684 poorly differentiated tumors 0.538507 clinical trials 0.807326 observational studies 0.567664 cancer information summary 0.707707 breast cancer prevention 0.552706 bilateral inguinal lymph 0.695554 penile HPV 0.678754 NCI’s PDQ 0.530402 PDQ Adult Treatment 0.603184 NCI PDQ cancer 0.668979 stage IV cancer 0.495897 lymph nodes 0.744697 regional inguinal lymph 0.679281 human papillomavirus 0.609539 positive lymph nodes 0.642063 penile cancer. 0.820523 single case 0.4576 antibiotic therapy 0.431816 node metastasis 0.456545	United States 0.583912 new drugs 0.43228 decreased risk 0.457358 microscopic node metastases 0.575056 node dissection 0.478206 prophylactic lymphadenectomy 0.435367 penile cancer 0.96059 National Cancer Institute 0.555757 distant metastases 0.467783 PDQ documents 0.502265 case series studies 0.559492 precursor lesions progress 0.546799 local control 0.438046 Bowen disease 0.435373 inguinal lymph node 0.850704 adjunctive inguinal dissection 0.622563 male newborn circumcision 0.57819 invasive penile cancer. 0.789576 case reports 0.439988 surgical techniques 0.438147 bilateral ilioinguinal dissection 0.579916 confidence interval 0.450369 Inguinal adenopathy 0.494134 human papillomavirus DNA 0.562566	CLICK HERE
1489	National Cancer Institute	Html	en	Salivary Gland Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of salivary gland cancer.	salivary gland carcinoma 0.511905 salivary duct carcinoma 0.495372 salivary neoplasms 0.436633 salivary gland neoplasms 0.699057 salivary gland tumors 0.679256 Oral Surg Oral 0.463588 Oral Med Oral 0.447637 Med Oral Pathol 0.44551 Labial salivary gland 0.469995 malignant salivary gland 0.526645 salivary gland neoplasm 0.484554 acinic cell carcinoma 0.43649 Salivary Gland Disease 0.467146 minor salivary glands 0.598035 epithelial salivary gland 0.497367 minor salivary glands. 0.45198 Gnepp DR 0.473942 Auclair PL 0.442506 salivary gland tissue 0.459874 Ellis GL 0.451621 salivary gland 0.899362 mesenchymal salivary gland 0.475624 mucoepidermoid carcinoma 0.443769 intraoral minor salivary 0.423491	Salivary gland tumours 0.500385 salivary gland lesion 0.478189 intraoral salivary glands 0.465746 parotid gland 0.430561 adenoid cystic carcinoma 0.455777 PUBMED Abstract 0.424085 major salivary glands 0.755909 salivary gland neoplasms. 0.489141 salivary gland register 0.455761 minor salivary gland 0.596497 common salivary gland 0.491012 Central salivary gland 0.46762 salivary gland accessions 0.477176 cell carcinoma 0.493942 salivary gland regions 0.454552 salivary gland sites 0.489141 Abstract 0.471491 salivary glands. 0.452306 salivary glands 0.905936 Surg Oral Med 0.463412 salivary gland tumor 0.497715 major salivary gland 0.545945 major salivary glands. 0.437313 salivary gland origin 0.593941	CLICK HERE
1907	National Cancer Institute	Html	es	Tratamiento de la leucemia linfoblástica aguda en adultos (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la leucemia linfoblástica aguda en adultos.	siguientes procedimientos 0.512309 células madre 0.745172 posibles factores 0.503357 leucemia linfocítica aguda 0.520357 sudores nocturnos 0.503905 leucemia linfoblástica aguda 0.974441 células madre formadoras 0.514124 hueso compacto 0.512997 neoplasias mieloides 0.503724 vía oral 0.502952 rayos x 0.503057 tirosina cinasa mesilato 0.506883 enlace drugs approved 0.528959 largo plazo 0.502247 cromosoma filadelfia 0.520834 célula madre mieloide 0.525688 células t 0.514618 efectos tardíos 0.513015 células anormales.ampliar aspiración 0.521673 líquido cefalorraquídeo 0.529356 punción espinal.Ampliar 0.503734	National Cancer Institute 0.502969 siguientes riesgos 0.502423 Instituto Nacional 0.509996 célula madre linfoide 0.511194 PDQ Tratamiento 0.507876 general empeora 0.503285 presente sección 0.502319 leucemia mielógena 0.512372 sistema nervioso central 0.612 Physician Data Query 0.510454 linfocitos t 0.513897 leucemia mieloide aguda 0.535285 siguientes enlaces 0.502726 célula madre 0.560418 células sanguíneas maduras 0.551656 células formadoras 0.516721 Filadelfia".Ampliar Cromosoma Filadelfia 0.507706 terapia posremisión 0.505736 cuidado paliativo 0.502192 siguientes pruebas 0.518516	CLICK HERE
2009	National Cancer Institute	Html	es	Trasplante de células hematopoyéticas en la niñez (PDQ®)–Versión para profesionales de salud	Información revisada por expertos acerca del uso del trasplante de células madre hematopoyéticas para el tratamiento del cáncer infantil.	mujeres donantes 0.306393 múltiples incompatibilidades 0.305809 HLA A 0.36555 incompatibilidades ich-o 0.306724 células progenitoras 0.322599 Sin embargo 0.310448 mejores abordajes 0.305856 cordón umbilical mo 0.310246 bone marrow relapse 0.305504 células t 0.3408 Marrow Transplant 0.341721 Moderado Bajo 0.314512 donantes momentos 0.307307 stem cell transplantation 0.321131 clase ii 0.317893 donante fraterno 0.317133 madre hematopoyéticas cmsp 0.31029 Children's Oncology Group 0.30909 intensive chemotherapy 0.305653 TCH satisfactorios 0.311984 siguientes antígenos 0.307763 donantes mujeres 0.306338 Transplant Clinical Trials 0.309697 HLA DRB1 0.341366 eich aguda 0.310608	DRB1 HLA DQB1 0.319182 dirección r-o 0.30821 HLA DPB1 0.318384 células madre 0.997289 donantes varones 0.306485 células cd34+ 0.310327 leucemia linfoblástica aguda 0.30978 marrow transplantation versus 0.305832 bone marrow transplantation 0.335932 Clinical Trials Network 0.307815 stem cell 0.328901 Oncology Group study 0.308699 células cd34 0.331629 antígeno hla 0.332107 Blood Marrow Transplant 0.306328 células madre hla 0.331292 eich aguda moderado 0.306115 PDQ Tratamiento 0.308981 bone marrow 0.352242 células progenitoras cd34 0.312061 Marrow Transplant Research 0.305769 células madre resultante 0.314653 incompatibilidades r-o 0.306646 EICH crónica 0.314484	CLICK HERE
4388	National Cancer Institute	Html	en	Risk Factors for Cancer	Information about behaviors, exposures, and other factors that may influence the risk of cancer.	possible inherited cancer 0.579042 sign 0.325482 section 0.325244 protective factors 0.646351 avoidable risk factors 0.633812 media 0.323442 type 0.323483 certain behaviors 0.496195 wrong ideas 0.432065 research 0.328222 result 0.323043 true risk factor 0.577461 things 0.325771 Common Cancer Myths 0.549129 Hereditary Cancer Syndromes 0.581459 Misconceptions page 0.432753 relationship 0.322662 increased risk 0.439428 chemicals 0.326011 potential risk factor 0.567711 risk factors 0.923045 certain substances 0.487633	genetic mutations 0.443709 chance 0.323016 protective risk factors 0.672248 certain cancers 0.611938 lower risk 0.460281 epidemiology studies 0.437177 large groups 0.438561 finding 0.323802 people 0.373455 certain risk factors 0.746622 exposure 0.356743 chances 0.333077 scientists 0.343939 family history 0.579318 certain ways 0.482584 person 0.360237 Cancer risk factors 0.679541 n’t 0.355491 cancer 0.820183 information 0.349749 similar association 0.428532 possible mechanism 0.423041	CLICK HERE
15634	National Cancer Institute	Html	en	Step 3: Peer Review and Funding Outcomes	The NCI review process seeks to achieve a balanced grant portfolio, that addresses scientific priorities. Learn about NCI’s peer review for grant applications.	Final funding decisions 0.68801 conservative funding range 0.692235 Funding Opportunity Announcement 0.669325 grant applications 0.543909 grant review cycle 0.655483 previously reviewed submissions 0.591298 scientific research community 0.67817 grants management specialist 0.65539 JIT requirements 0.569359 NCI budget 0.675257 specific grant application 0.663769 funding guidelines 0.594989 Grants Policy Manual 0.654435 grants management 0.718868 Resubmission Applications 0.561239 additional information 0.630031 funding mechanisms 0.587684 future funding 0.591477 preliminary funding allocations 0.74522 JIT Procedures 0.570833 program allocations 0.582504 program priorities 0.540659 NCI division 0.672087 grants management staff 0.632016 JIT information 0.763408	review percentile/impact score 0.647883 NIH Policy 0.59572 responsible NIH official 0.747181 Peer Review process 0.887529 NCI Scientific Program 0.984221 NCI Peer Review 0.873194 important scientific priorities 0.646164 nih peer review 0.942228 Program Leadership Committee 0.639488 subsequent new application 0.637696 unsuccessful initial submission 0.60519 scientific program staff 0.658004 Scientific Review 0.61867 promising scientific opportunities 0.644998 administrative review 0.543867 following JIT information 0.687226 NCI grants process 0.840796 unsuccessful initial application 0.638737 scientific merit 0.540216 Scientific Program Leadership 0.821474 funding decisions 0.80612 dual review process 0.70096 timely review 0.580483 Public Health Service 0.644114	CLICK HERE
16643	National Cancer Institute	Html	es	Régimen Gonzalez (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso del régimen Gonzalez como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	Centro Nacional 0.304069 New Hampshire Avenue 0.301293 Drug Administration 0.300803 estadio ii 0.30117 NCI Best Case 0.302468 datos bibliográficos pubmed 0.301383 siguientes preguntas 0.300833 supervivencia promedio 0.301242 James Beard 0.301166 PDQ Régimen Gonzalez 0.309993 National Cancer Institute 0.301582 estudio clínico 0.301423 siguientes riesgos 0.301039 Instituto Nacional 0.310951 Salud Complementaria 0.305346 Visuals Online 0.30094 complementarias revisa 0.301324 siguientes efectos 0.301323	Physician Data Query 0.305467 enzimas pancreáticas 0.367516 Estados Unidos 0.312379 régimen gonzalez 0.988904 libre uso 0.300947 página manejo 0.300877 Medicina Alternativa 0.30166 ¿El tratamiento 0.301547 ¿Los beneficios 0.30081 juntos cam 0.300775 siguientes formas 0.301287 William Kelley 0.301175 Clinical Oncology 0.301179 Nicholas Gonzalez 0.323344 Max Gerson 0.301216 enzimas.Los resultados 0.300995 Series Program 0.300797 medicina complementaria 0.336883	CLICK HERE
16849	National Cancer Institute	Html	en	Earlier Detection and Diagnosis	Winning the battle in cancer is by way of its earlier detection. Find out here how nanotechnology for cancer can enable the next generation of diagnostics.	molecular contrast agents 0.744126 magnetic resonance 0.73913 gold nanoparticles 0.758974 contrast agents 0.928653 specific tumor type 0.759045 nanoparticles 0.799664 Kettering Cancer Center 0.72147 single cancer cell 0.739114 prostate cancer cells 0.750158 local tumor response 0.753856 self-assemblying nanoparticles 0.709894 image contrast agents 0.719631 current nanoscale imaging 0.726633 tumor specific tissue 0.778585 tumor types 0.710578 magnetic resonance imaging 0.73549 tissue biopsies 0.710788 single cell level 0.706857 tumor tissue 0.754041 cancer cells 0.798935 magnetic nanoparticles 0.748727 Current imaging methods 0.720015 surgical resection 0.752605 molecular imaging agents 0.749026 imaging contrast agents 0.752812	Bioactivatable nanoparticles 0.713538 tumor pre-seeding 0.710938 novel imaging modalities 0.716395 tumor growth 0.708481 clinical cancer imaging 0.759447 tumor cells 0.829828 optical imaging contrast 0.737025 lung cancer patients 0.707897 Stanford University 0.729305 modern imaging modalities 0.717085 biological signatures 0.716262 cancer detection 0.708688 clinical cancer treatment 0.738765 brain tumor 0.708929 single circulating tumor 0.753922 cancer cell death 0.775613 Raman spectroscopic imaging 0.712792 imaging modalities 0.740521 MRI-PAT-Raman nanoparticles 0.710131 silica-hybrid nanoparticles 0.709652 prostate cancer 0.754477 tumor DNA 0.744446 cancer patient treatment 0.749464 cell-free tumor DNA 0.731784	CLICK HERE
17276	National Cancer Institute	Html	es	Su propio cuidado	Cuidar a alguien con cáncer avanzado trae desafíos y preocupaciones nuevas. Es importante que también se cuide a usted mismo y que pida ayuda.	Lotsa Helping Hands 0.77931 busque ayuda 0.925738	tanta emoción 0.963692	CLICK HERE